CUR­RENT CLIN­I­CAL TRI­ALS FOR ALZHEIMER’S DISEASE

BioSpectrum (Asia) - - Analysis - Source: Vanessa Jane Hall (http://sci­en­cenordic.com - dated March 17, 2018)

Global:

Phase 1: 25 drugs, 29 tri­als

Phase 2: 52 drugs, 68 tri­als

Phase 3: 28 drugs, 42 tri­als

Phase 4: 7 (i.e. these have suc­cess­fully com­pleted Phase 3 test­ing).

Ap­prox­i­mately 66 have been dis­con­tin­ued. Europe:

Nine reg­is­tered tri­als driven by large phar­ma­ceu­ti­cal com­pa­nies, such as Eli Lilly, Hoff­mann-La Roche, Janssen, Bio­gen, Ei­sai, AZTher­a­pies and No­var­tis.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.